Carbohydrate 19-9 Antigen as a Marker of Non-Malignant Hepatocytic Ductular Transformation in Patients with Acute Liver Failure: A Comparison with Alpha-Fetoprotein and Carcinoembryonic Antigen

References

• Seta N, Gayno S, Jezequel-Cuer M, Toueg M-L, Erlinger S, Durand G. Sequential study of serum glucoprotein fucosylation in acute hepatitis. J Hepatol 1997;26:265–71.
   Google Scholar
• Ruoslahti E, Salaspuro M, Pihko H, Andersson L, Seppala M. Serum a-fetoprotein: diagnostic significance in liver disease. Br Med J 1974;8:527–9.
   Google Scholar
• Thomas P, Zamcheck N. Role of liver in clearance and excretion of circulating carcinoembryonic antigen (CEA). Dig Dis Sci 1983;28:216–24.
   PubMed Web of Science ®Google Scholar
• Magnani JL, Nilsson B, Brockhaus M, Zopf D, Steplewski Z, Koprowski H, et al. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem 1982;257: 14365–9.
   PubMed Web of Science ®Google Scholar
• Dietel M, Arsp H, Kapdor R, Muller-Hagen S, Sieck M, Hoffmann L. Antigen detection by the monoclonal antibodies CA 19–9 and CA 125 in normal and tumor tissue and patient’ sera. J Cancer Res Clin Oncol 1986;111: 257–65.
   Google Scholar
• Steinberg WM, Gelfand R, Anderson KK, Glenn J, Kurtzmann SH, Sindelar WF, et al. Comparison of the sensitivity and specificity of the Ca 19–9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology 1986;90: 343–9.
   PubMed Web of Science ®Google Scholar
• Collazos J, Genolla J, Ruibal A. Ca 19–9 in non-neoplastic liver diseases. A clinical and laboratory study. Clin Chim Acta 1992; 210:145–51.
   PubMedGoogle Scholar
• Minato H, Nakanuma Y, Terada T. Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts. Histopathology 1996;28:411–9.
   Google Scholar
• Bogulawski von K. Immunohistochemical detection of progesterone receptors in paraffin sections. A novel method using microwave oven pretreatment. APMIS 1994;102:641–6.
   Google Scholar
• Putzki H, Ledwoch J, Student A, Jablonski M, Heymann H. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen and carbohydrate antigen 19/9 in liver diseases. J Surg Oncol 1988;37: 133–5.
   Google Scholar
• Fabris C, Basso DA, Leandro G, Meggiato T, Elba S, Panozzo MP, et al. Serum Ca 19–9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. Cancer 1991;68:1795–8.
   PubMed Web of Science ®Google Scholar
• Deugnier YM, Rabot A-F, Guyader D, Moirand R, Turlin B, Boucher E, et al. Serum increase and liver overexpression of carbohydrate 19.9 antigen in patients with genetic haemochro-matosis. Gut 1994;35: 1107–11.
   Google Scholar
• Sameshima Y, Chia D, Terasaki PI, Imagawa DK, Busuttil RW. Appearance of tumor marker Ca 19–9 in liver transplant patients during rejection episodes. Transplantation 1992;53: 580–2.
   Google Scholar
• Haglund C, Lindgren J, Roberts PJ, Nordling S. Difference in tissue expression of tumor markers CA 19–9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma. Br J Cancer 1991;63:386–9.
   PubMedGoogle Scholar
• Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995;108: 865–9.
   Google Scholar
• Nichols JC, Gores GJ, LasRusso NF, Wiesner RH, Nagorney DM, Ritts RE. Diagnostic role of serum Ca 19–9 for cholangio-carcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993;68:874–9.
   PubMed Web of Science ®Google Scholar
• Fabris C, Falleti E, Pirisi M, Soardo G, Toniutto P, Vitulli D, et al. Non-specific increase of serum carbohydrate antigen 19–9 in patients with liver disease associated with increased circulating levels of adhesion molecules. Clin Chim Acta 1995;243:25–33.
   PubMed Web of Science ®Google Scholar
• Pearce S, Thornes H, Carr D, Tanner A. Diagnostic pitfall; interpretation of Ca 19–9 concentrations in the presence of hepatic dysfunction. Gut 1994;35:707–8.
   PubMedGoogle Scholar
• Turtel PS, Kreel I, Israel J, Frager D, Berman D. Elevated Ca 19–9 in a case of Mirizzi’s syndrome. Am J Gastroenterol 1992;87: 355–7.
   Google Scholar
• Gerber MA, Thung SN, Shen S, Stromeyer FW, Ishak KG. Phenotypic characteristization of hepatic proliferation: antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. Am J Pathol 1983;110:70–4.
   Google Scholar
• Delladetsima JK, Kyrlakou V, Vafiadis I, Karakitsos P, Smyrn-off T, Tassopoulos NC. Ductular structures in acute hepatitis with panacinar necrosis. J Pathol 1995;175:69–76.
   Google Scholar
• Demetris AJ, Seaberg EC, Wennerberg A, Ionellie J, Michalo-poulos G. Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes. Am J Pathol 1996;149:439–48.
   Google Scholar
• Thung SN. The development of proliferating ductular structures in the liver disease: an immunohistochemical study. Arch Pathol Lab Med 1990;14:407–11.
   Google Scholar
• Popper H. The relation of mesenchymal cell products to hepatic epithelial systems. Prog Liver Dis 1990;9:27–38.
   PubMedGoogle Scholar
• Kokoulis G, Rayner A, Tan KC, Williams R, Portmann B. Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining. J Pathol 1992;166:359–68.
   Google Scholar
• Rubin EM, Martin AA, Thung SN, Gerber MA. Morphometric and immunohistochemical characterization of human liver regeneration. Am J Pathol 1995;147:397–404.
   PubMedGoogle Scholar
• Sell S. Is there a liver stem cell? Cancer Res 1990;50:3811–5.
   PubMed Web of Science ®Google Scholar
• Terada T, Nakanuma Y. Profiles of expression of carbohydrate chain structures during human intrahepatic bile duct development and maturation: a lectin-histochemical and immunohisto-chemical study. Hepatology 1994;29:388–97.
   Google Scholar
• Nakanuma Y, Sasaki M. Expression of blood group related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases. Hepatology 1989;10:174–8.
   PubMedGoogle Scholar
• Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohis-tochemical study of cholestatic liver disease: evidence that hepatocytes can express ‘bile duct type’ cytokeratins. Histopathology 1989;15:125–35.
   Google Scholar
• Gerber MA, Thung SN. Liver stem cells and development. Lab Invest 1993;68:253–4.
   PubMedGoogle Scholar
• Fiel MI, Antonio LB, Nalesnik MA, Thung SN, Gerber MA. Characterization of ductular hepatocytes in primary liver allograft failure. Mod Pathol 1997;10:348–53.
   Google Scholar
• Vandersteenhoven A, Burchette J, Michalopoulos G. Characterization of ductular hepatocytes in end-stage cirrhosis. Arch Pathol Lab Med 1990;114:403–6.
   PubMedGoogle Scholar